Companies: 10,795·Total market cap: $144.5T
PURE Bioscience, Inc.

PURE Bioscience, Inc.

PUREOTCConsumer Defensive● Active
$0.07
$-0.00(-2.67%)
Market Cap$7328533
P/E Ratio
52W High$0.14
52W Low$0.04
Overview

PURE Bioscience, Inc. (PURE) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · PURE · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.02pure eps ttm · pure earnings per shareEarnings history
PE Ratio (TTM)pure pe ratio ttm · pure price to earningsPE Ratio deep dive
Revenue (TTM)$2.4Mpure revenue ttm · pure annual revenueFull revenue history
Dividend YieldNo Dividenddoes pure pay dividends · pure dividend yieldDividend history
Shares Outstanding111.9Mpure shares outstanding · pure floatShares outstanding history
Next EarningsJun 16, 2026Est.pure earnings date · pure next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$2.2M▲ +12.18% YoY
202320242025
pure bioscience, inc. revenue · pure revenue 2025
FY 2025Net Income-$2.4M▲ +28.39% YoY
202320242025
pure bioscience, inc. net income · pure profit 2025
FY 2025EPS$-0.02▲ +28.43% YoY
202320242025
pure eps · pure bioscience, inc. earnings per share 2025
TTM:Revenue: $2.4MNet Income: -$2.2MEPS: $-0.02View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold1 analystsis pure a buy · pure analyst rating
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.07Current
$Avg Target
$High
pure price target · pure 12 month forecast

Total: 1 · Buy rate: 0.0%

Stock Performance

Full History
1D-2.67%
1W-2.70%
1M-4.24%
3M+9.17%
YTD+55.95%
1Y-34.94%
5Y-86.77%

About PURE Bioscience, Inc.

CEORobert F. Bartlett
IPO DateAug 8, 1996
Employees11
CountryUS

PURE Bioscience, Inc. specializes in the creation and market introduction of advanced antimicrobial solutions. These products are designed to tackle critical health and environmental issues related to…

what is pure bioscience, inc. · pure stock overview · pure bioscience, inc. company profile · who is pure bioscience, inc. ceo · pure OTC · pure bioscience, inc. headquarters · pure bioscience, inc. business segments

About Stock Overview & Key Data

PURE Bioscience, Inc. (PURE) is a Consumer Defensive company in the Household & Personal Products industry, listed on OTC since Aug 8, 1996. As of the latest trading session, PURE stock price is $0.07, with a market capitalization of $7.3M. The stock has returned -34.94% over the past 12 months and +55.95% year-to-date.

According to 1 Wall Street analysts, the consensus rating for PURE Bioscience, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, PURE Bioscience, Inc. reported revenue of $2.2M and net income of -$2.4M. For detailed data — including PURE Bioscience, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, PURE Bioscience, Inc. (PURE) stock price is $0.07. The stock is traded on OTC under the ticker symbol PURE. The 52-week range is $0.04 – $0.14.

PURE stock pricePURE quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice